[95F8-95F8];[95F14-95F14];
A set of ~800 largely isogenic deficiency stocks created by FLP-induced recombination between FRT-carrying transgenic insertions; molecularly defined deletion endpoints correspond to initial location of the progenitor insertions. Designed to fill gaps in deletion coverage and breakpoint placement; also used to replace older available deficiencies that have not been molecularly mapped.
95F8;95F14
Breakpoint from FlyBase's release 5 sequence location of progenitor insertion.
Inferred to overlap with: Df(3R)BSC317.
crb11A22/Df(3R)BSC638 stage 11 mutants have increased neuroblast numbers when compared to control embryos.
The presence of P+PBac{XP5.RB3}BSC638 was verified using the PCR methods and primers described in FBrf0175003, with the substitution of the primer 5'-GCTTCTAAACGCTTACGCATAAACGATG-3' for the RB3' plus or RB3' minus primer in the Hybrid PCR protocol in the Supplementary Methods.
The cytological breakpoints of Df(3R)BSC638 predicted from the Release 5 genomic coordinates of the insertion sites of the progenitor transposable elements P{XP}d02406 and PBac{RB}e03557 are 95F8;95F14.